Welcome to BioTech Nation !!! With comprehensible interviews, BTN podcasts attract a wide global audience - from bioentrepreneurs interested in the bioentrepreneurship journey, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists seeking insights from the work of others, to everyday people looking for hope from new treatments under development. BioTech Nation is the voice of human endeavor, an endeavor that will benefit many, and sometimes, all. These interviews are drawn directly from the public radio program, "Tech Nation", which can be heard on domestic and global radio, as well as through your favorite podcasting venues.

Latest Episodes

How 200 Snake Bites Became a Universal Antivenom...Dr. Jake Glanville, Founder, CEO, Chair of Centivax

This week on BioTech Nation, a call to a man who survived hundreds of venomous snake bites helps inspire the development of an antivenom vaccine. Biotech Entrepreneur,...

Hospital at Home? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent

On this week's BioTech Nation, Tech Nation Health Chief Correspondent Dr. Daniel Kraft tells us about the trend of "hospital-at-home". As we see the expansion of remot...

A Not-in-the-Textbooks Discovery for Glioblastoma, Jay Hartenbach & Dr. Will Decker, Diakonos Oncology

On this episode of BioTech Nation, Dr. Will Decker and Jay Hartenbach join Moira to talk about Diakonos Oncology's unique approach to cancer immunotherapy, and how a d...

Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals

On this episode of BioTech Nation: how Syndax Pharmaceuticals got two new drugs approved in the last two years, for the treatment of acute myeloid leukemia and graft v...

Fighting Hard-to-Treat Cancers...Dan Schmitt, President & CEO, Actuate Therapeutics

On this episode of BioTech Nation, Dan Schmitt of Actuate Therapeutics talks about a new kind of drug showing positive early results in hard-to-treat cancer - includin...

More Episodes »
Broadcast by